期刊文献+

D-、L-和DL-青霉胺的太赫兹时域光谱 被引量:28

Terahertz Time-Domain Spectroscopy of D-,L-,and DL-Penicillamines
下载PDF
导出
摘要 利用太赫兹时域光谱技术(THz-TDS)对D-、L-和DL-青霉胺的研究发现,三种样品在0.2THz到1.8THz波段的吸收光谱存在显著差异,实验结果表明,THz吸收光谱能够鉴别青霉胺对映异构体,这一特点将可以用于青霉胺药物的检测.本文利用纯D-、L-青霉胺的THz吸收光谱,对D-、L-青霉胺混合样品的THz吸收光谱进行拟合,证明可以用THz光谱定量分析混合样品中D-、L-青霉胺的相对含量.这项研究为手性药物分子检测和分析提供了新的实验方法,也对深入了解手性药物与生物靶分子之间相互作用提供了启示. Far-infrared absorption spectra of D-, L-, and DL- penicillamines have been measured by terahertz timedomain spectroscopy (THz-TDS) in the frequency range from 0.2 THz to 1.8 THz. The experimental results show large difference among absorption spectra of enantiomers (D- and L- peniciUamines) and their racemic compound (DL- penicillamine), which probably originated from the difference of crystal structure and vibration modes of crystal lattice. The study indicates that THz-TDS can be used for discrimination of D-, L-, and DL- peniciUamines. The absorption spectra of their mixtures have been fitted by the absorption spectra of D- and L- penicillamines, and we have demonstrated the feasibility of this method to determine quantitatively the mixture ratios of penicillamine enantiomers. These will not only give a new experimental method to distinguish chiral medicine, but also provide a suggestion for further comprehending the interaction of chiral medicine and target biomolecule.
出处 《物理化学学报》 SCIE CAS CSCD 北大核心 2006年第9期1159-1162,共4页 Acta Physico-Chimica Sinica
基金 国家自然科学基金(10574134) 中国科学院知识创新工程资助项目
关键词 太赫兹时域光谱 D-、L-、DL-青霉胺 对映异构体 定量分析 THz-TDS, D-, L-, and DL- penicillamines, Enantiomers, Quantitative analysis
  • 相关文献

参考文献18

  • 1Ferguson,B.;Zhang,X.C.Nature Materials,2002,1(1):26
  • 2Markelz,A.G.;Roitberg,A.;Heilweil,E.J.Chem.Phys.Lett.,2000,320:42
  • 3Walther,M.;Plochocka,P.;Fischer,B.;Helm,H.;Jepsen,P.U.Biopolymers,2002,67:310
  • 4Chen,Y.Q.;Liu,H.B.;Deng,Y.Q.;Schauki,D.;Fitch,M.J.;Osiander,R.;Dodson,C.;Spicer,J.B.;Shur,M.;Zhang,X.C.Chem.Phys.Lett.,2004,400:357
  • 5Strachan,C.J.;Rades,T.;Newnham,D.A.;Gordon,K.C.;Pepper,M.;Taday,P.F.Chem.Phys.Lett.,2004,390:20
  • 6Zhang,J.Q.;Grischkowsky,D.Opt.Lett.,2004,29(9):1031
  • 7Walther,M.;Fischer,B.;Schall,M.;Helm,H.;Jepsen,P.U.Chem.Phys.Lett.,2000,332:389
  • 8Yamaguchi,M.;Miyamaru,F.;Yamamoto,K.;Tani,M.;Hangyo,M.Appl.Phys.Lett.,2005,86(5):053903
  • 9Wang,W.N.;Yue,W.W.;Yan,H.T.;Zhang,C.L.;Zhao,G.Z.Chinese Science Bulletin,2005,50(15):1561
  • 10Shi,Y.L.;Wang,L.J.Phys.D:Appl.Phys.,2005,38:3741

二级参考文献32

  • 1Amato I. Looking glass chemistry [J]. Science, 1992, 256:964.
  • 2Higaki K, Nakano M. Stereoselective disposition of S-8666,a novel uricosuric antihypertensive diuretic, and its N-monodemethylated metabolite in a perfused rat liver preparation.Effect of protein binding on the kinetics of S-8666 [J]. Drug Metab Dispos, 1992, 20(3): 350.
  • 3Haussermann K, Benz B, Gekeler V, et al. Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines [J]. Eur J Clin Pharmacol, 1991,40(1): 53.
  • 4Eichelbaum M. Enantiomers: implications and complications in developmental pharmacology [J]. Dev Pharmacol Ther,1992, 18(3-4): 131.
  • 5Kean WF, Lock C J, Rischke J, et al. Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets [J]. J Pharm Sci, 1989, 78(4): 324.
  • 6Ariene EJ. Sterochemistry and Biological Activity of Drugs [M]. Blackwell, Oxford, 1983: 11.
  • 7Lepola U, Arato M, Zhu Y, et aL Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder [J]. J Clin Psychiatry, 2003, 64(6): 654.
  • 8Kamiya Y, Andoh T, Furuya R, et al. Comparison of the effects of convulsant and depressant barbiturate stereoisomers on AMPA - type glutamate receptors [J] . Anesthesiology,1999, 90(6): 1704.
  • 9Akbar H, Navran SS, Miller DD, et al. Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin- independent pathway of platelet aggregation [J] .Biochem Pharmacol, 1982, 31(5): 886.
  • 10Leander JD, Zimmerman DM. Effects of picenadol and its agonist and antagonist isomers on schedule-controlled behavior [J]. J Pharmacol Exp Ther, 1983, 227(3): 671.

共引文献23

同被引文献320

引证文献28

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部